Inhaled Sedation in Critically Ill Patients
Inhaled Sedation in Critically Ill Patients: a Multicentre Randomized Clinical Trial
Instituto de Investigación Hospital Universitario La Paz
620 participants
Dec 15, 2025
INTERVENTIONAL
Conditions
Summary
The proposal of this study is to compare inhaled sedation with isoflurane administered via the Sedaconda ACD-S system with intravenous sedation with propofol. Patients will be randomized 1:1 to receive either inhaled sedation with isoflurane administered via the Sedaconda ACD device (Sedana Medical, Uppsala, Sweden) or intravenous propofol. The primary endpoint is the number of ventilator-free days at 28 days after randomization.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Inhaled sedation with isoflurane via Sedaconda ACD-S
Intravenous sedation with Propofol 20 mg/ml
Locations(22)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07000526